TUDOR INVESTMENT CORP ET AL
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 923093
STAMFORD, CT
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,671,482
+$256,679 QoQ
Shares Held
46,021
+15.7% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 50%
Shared 50%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
943,287 | $66,643,226 | |
| 2 | RPRX |
Royalty Pharma plc
|
610,736 | $34,243,967 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
545,387 | $32,919,559 | |
| 4 | ABVX |
Abivax S.A.
|
187,335 | $24,964,262 | |
| 5 | INSM |
INSMED Inc
|
195,391 | $20,832,588 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
738,370 | $19,921,222 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
2,063,191 | $16,196,049 | |
| 8 | QURE |
uniQure N.V.
|
328,889 | $15,148,627 |
All Filings in CRNX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,671,482 | 46,021 | Shares | Defined | 2026-05-15 | |
| 2023-12-31 | $1,414,803 | 39,764 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $981,420 | 33,000 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $487,044 | 27,028 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $525,428 | 26,753 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||